Results 31 to 40 of about 12,561 (235)

Bullous pemphigoid

open access: yesIndian Journal of Dermatology, Venereology, and Leprology, 2011
Bullous pemphigoid (BP) is a relatively common autoimmune vesicobullous disease encountered in India. It is a subepidermal bullous disorder most commonly seen in the elderly and manifests as tense blisters on urticarial base, predominantly over flexures, and is associated with pruritus.
Sujay, Khandpur, Parul, Verma
openaire   +2 more sources

Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid

open access: yesJEADV Clinical Practice, 2023
Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma   +2 more
doaj   +1 more source

Bullous Pemphygoid and Novel Therapeutic Approaches

open access: yesBiomedicines, 2022
Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately.
Giovanni Marco D’Agostino   +10 more
doaj   +1 more source

Resolution in bullous pemphigoid [PDF]

open access: yesSeminars in Immunopathology, 2019
AbstractPemphigoid diseases are a group of autoimmune blistering skin diseases defined by an immune response against certain components of the dermal-epidermal adhesion complex. They are prototypical, autoantibody-driven, organ-specific diseases with the emergence of inflammatory skin lesions dependent on the recruitment of immune cells, particularly ...
Christian D. Sadik, Enno Schmidt
openaire   +2 more sources

Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature

open access: yesActa Dermato-Venereologica, 2021
Bullous pemphigoid constitutes a rare dermatological immune-related adverse event of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors.
Aikaterini Tsiogka   +2 more
doaj   +1 more source

Forest plot of the association between positive bullous pemphigoid 180 antibody and bullous pemphigoid mortality.

open access: yes, 2022
Forest plot of the association between positive bullous pemphigoid 180 antibody and bullous pemphigoid mortality.
Yaqiang Zhang (9258692)   +6 more
core   +1 more source

Correlation between bullous pemphigoid and type 2 inflammation

open access: yesPifu-xingbing zhenliaoxue zazhi, 2022
Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU   +6 more
doaj   +1 more source

Mortality of bullous pemphigoid in Switzerland: a prospective study

open access: yes, 2011
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and has been associated with a significant morbidity and an increased mortality ...
Combescure, C   +5 more
core   +1 more source

Scabies masquerading as bullous pemphigoid: scabies surrepticius

open access: yes, 2017
Philip R Cohen Department of Dermatology, University of California San Diego, La Jolla, CA, USA Abstract: Scabies, a parasitic infestation caused by the mite Sarcoptes scabiei, is diagnosed by observing either the mite, its ova, or its ...
Cohen PR, Philip R Cohen
core   +1 more source

Bullous Pemphigoid Causing Successive Emergency Department Visits [PDF]

open access: yes, 2023
Case Presentation: In this case presentation, an 84-year-old male with Fitzpatrick type IV skin tone experienced blistering due to bullous pemphigoid (BP), first on the distal upper left extremity and then on the distal lower extremities, chest, and back.
Kinoshita, Andrew T.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy